Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

SMO Clinplus Co stock price, quote, forecast and news

301257.SZ
CNE100005CP8

Price

29.30
Today +/-
+0.15
Today %
+3.97 %
P

SMO Clinplus Co stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the SMO Clinplus Co stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the SMO Clinplus Co stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the SMO Clinplus Co stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze SMO Clinplus Co's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

SMO Clinplus Co Stock Price History

DateSMO Clinplus Co Price
8/6/202429.30 undefined
8/5/202428.16 undefined
8/2/202428.92 undefined
8/1/202428.02 undefined
7/31/202427.88 undefined
7/30/202426.60 undefined
7/29/202426.08 undefined
7/26/202426.37 undefined
7/25/202426.21 undefined
7/24/202425.98 undefined
7/23/202426.56 undefined
7/22/202427.58 undefined
7/19/202426.58 undefined
7/18/202426.76 undefined
7/17/202426.94 undefined
7/16/202426.53 undefined
7/15/202426.79 undefined
7/12/202427.80 undefined
7/11/202427.50 undefined
7/10/202426.31 undefined
7/9/202426.44 undefined

SMO Clinplus Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into SMO Clinplus Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by SMO Clinplus Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects SMO Clinplus Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of SMO Clinplus Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into SMO Clinplus Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing SMO Clinplus Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on SMO Clinplus Co’s growth potential.

SMO Clinplus Co Revenue, EBIT and net profit per share

DateSMO Clinplus Co RevenueSMO Clinplus Co EBITSMO Clinplus Co Net Income
2026e1.43 B undefined0 undefined152.22 M undefined
2025e1.17 B undefined300.48 M undefined124.02 M undefined
2024e959.5 M undefined205.03 M undefined98.59 M undefined
2023e813.25 M undefined144.43 M undefined78.25 M undefined
2022586.23 M undefined73.37 M undefined72.41 M undefined
2021502.97 M undefined67.03 M undefined57.77 M undefined
2020335.29 M undefined42.75 M undefined35.32 M undefined
2019303.54 M undefined59.74 M undefined52.36 M undefined

SMO Clinplus Co Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20192020202120222023e2024e2025e2026e
0.30.340.50.590.810.961.171.43
-10.5649.8516.7338.7417.9622.1122.12
32.6728.9626.1027.13----
99971311590000
594267731442053000
19.4712.5413.3512.4617.7121.3825.62-
523557727898124152
--32.6962.8626.328.3325.6426.5322.58
60606060.980000
--------
Details

Keystats

ⓘ

Revenue and Growth

The SMO Clinplus Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the SMO Clinplus Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (k)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (k)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (B)
2019202020212022
89.56103.03135.65813.83
92.22159235.21314.79
3.496.556.362.21
0000
1.152.241.461.88
0.190.270.381.13
5.045.7611.3214.04
7.937.811.119.92
0000
149.17107.4355.28721.06
0000
2.392.883.093.33
15.5116.5425.5728.01
0.20.290.41.16
45454560.98
7.0611.5117.62652.36
73.13108.45166.22238.63
0000
0000
125.19164.96228.84951.97
0.010.018.889.75
27.7735.2848.5462.35
48.9487.02113.2132.23
22.191.9669.6669.66
003.74.03
76.74122.4174.39208.43
001.020.32
0000
0000
001.020.32
76.74122.4175.41208.75
0.20.290.41.16
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of SMO Clinplus Co provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand SMO Clinplus Co's financial health and stability.

Assets

SMO Clinplus Co's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that SMO Clinplus Co must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of SMO Clinplus Co after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into SMO Clinplus Co's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2019202020212022
0000
0000
0000
-192-238-341-426
0000
0000
-24-22-32-40
45224140
-4-4-4-7
-11-4-4-142
-600-134
0000
-1000
0000
-1-4-4643
0-4-4643
0000
0.290.30.451.05
40.6218.3637.1132.48
0000

SMO Clinplus Co stock margins

The SMO Clinplus Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of SMO Clinplus Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for SMO Clinplus Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the SMO Clinplus Co's sales revenue. A higher gross margin percentage indicates that the SMO Clinplus Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the SMO Clinplus Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the SMO Clinplus Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the SMO Clinplus Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the SMO Clinplus Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the SMO Clinplus Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

SMO Clinplus Co Margin History

SMO Clinplus Co Gross marginSMO Clinplus Co Profit marginSMO Clinplus Co EBIT marginSMO Clinplus Co Profit margin
2026e27.29 %0 %10.64 %
2025e27.29 %25.66 %10.59 %
2024e27.29 %21.37 %10.27 %
2023e27.29 %17.76 %9.62 %
202227.29 %12.52 %12.35 %
202126.08 %13.33 %11.49 %
202029.12 %12.75 %10.53 %
201932.88 %19.68 %17.25 %

SMO Clinplus Co Stock Sales Revenue, EBIT, Earnings per Share

The SMO Clinplus Co earnings per share therefore indicates how much revenue SMO Clinplus Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue SMO Clinplus Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates SMO Clinplus Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of SMO Clinplus Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating SMO Clinplus Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

SMO Clinplus Co Revenue, EBIT and net profit per share

DateSMO Clinplus Co Sales per ShareSMO Clinplus Co EBIT per shareSMO Clinplus Co Earnings per Share
2026e30.73 undefined0 undefined3.27 undefined
2025e25.16 undefined0 undefined2.66 undefined
2024e20.62 undefined0 undefined2.12 undefined
2023e17.47 undefined0 undefined1.68 undefined
20229.61 undefined1.2 undefined1.19 undefined
20218.38 undefined1.12 undefined0.96 undefined
20205.59 undefined0.71 undefined0.59 undefined
20195.06 undefined1 undefined0.87 undefined

SMO Clinplus Co business model

SMO Clinplus Co is one of the most popular companies on Eulerpool.com.

SMO Clinplus Co Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

SMO Clinplus Co historical P/E ratio, EBIT, and P/S ratio.

SMO Clinplus Co shares outstanding

The number of shares was SMO Clinplus Co in 2023 — This indicates how many shares 60.975 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue SMO Clinplus Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates SMO Clinplus Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of SMO Clinplus Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating SMO Clinplus Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

SMO Clinplus Co Stock splits

In SMO Clinplus Co's history, there have been no stock splits.

SMO Clinplus Co dividend history and estimates

In 2023, SMO Clinplus Co paid a dividend amounting to 0.18 CNY. Dividend means that SMO Clinplus Co distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for SMO Clinplus Co provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify SMO Clinplus Co’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating SMO Clinplus Co's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

SMO Clinplus Co Dividend History

DateSMO Clinplus Co Dividend
SMO Clinplus Co does not pay out any dividends.
Unfortunately, there are currently no price targets and forecasts available for SMO Clinplus Co.

SMO Clinplus Co list of shareholders

%
Name
Stocks
Change
Date
9.67 % Shihezi Ruizesheng Equity Investment Co., Ltd.4,500,00009/30/2023
7.68 % Lai (Chunbao)3,575,500160,0002/7/2024
3.24 % Zhong Ou Asset Management Co., Ltd.1,507,9951,348,6289/30/2023
24.42 % Shihezi Xitai Equity Investment Partnership (Limited Partnership)11,364,21009/30/2023
2.49 % Zhang (Jing)1,160,020-930,00011/24/2023
2.15 % Rongtong Fund Management Co., Ltd.1,000,000530,0009/30/2023
10.57 % Shihezi Ruixin Equity Investment Partnership (Limited Partnership)4,921,20009/30/2023
10.36 % Guanyou Zhaotai (Jiaxing) Equity Investment Partnership LP4,822,400-615,10010/20/2023
1.84 % Shanghai Hongjia Private Equity Fund Management Co., Ltd.857,500-924,8009/30/2023
1.74 % Mo (Jingxian)812,00038,3009/30/2023
1
2
3
4
5
...
7

Most common questions regarding SMO Clinplus Co

What is the P/E ratio of SMO Clinplus Co 2024?

The SMO Clinplus Co P/E ratio is 18.12.

What is the P/S ratio of SMO Clinplus Co 2024?

The SMO Clinplus Co P/S ratio is 1.86.

What is the AlleAktien quality score of SMO Clinplus Co?

The AlleAktien quality score for SMO Clinplus Co is 4/10.

What is the revenue of SMO Clinplus Co 2024?

The expected SMO Clinplus Co revenue is 959.5 M CNY.

How high is the profit of SMO Clinplus Co 2024?

The expected SMO Clinplus Co profit is 98.59 M CNY.

What is the business model of SMO Clinplus Co

No history available for SMO Clinplus Co.

What is the SMO Clinplus Co dividend?

SMO Clinplus Co pays a dividend of 0 CNY distributed over payouts per year.

How often does SMO Clinplus Co pay dividends?

The dividend cannot currently be calculated for SMO Clinplus Co or the company does not pay out a dividend.

What is the SMO Clinplus Co ISIN?

The ISIN of SMO Clinplus Co is CNE100005CP8.

What is the SMO Clinplus Co ticker?

The ticker of SMO Clinplus Co is 301257.SZ.

How much dividend does SMO Clinplus Co pay?

Over the past 12 months, SMO Clinplus Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, SMO Clinplus Co is expected to pay a dividend of 0.18 CNY.

What is the dividend yield of SMO Clinplus Co?

The current dividend yield of SMO Clinplus Co is .

When does SMO Clinplus Co pay dividends?

SMO Clinplus Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of SMO Clinplus Co?

SMO Clinplus Co paid dividends every year for the past 0 years.

What is the dividend of SMO Clinplus Co?

For the upcoming 12 months, dividends amounting to 0.18 CNY are expected. This corresponds to a dividend yield of 0.6 %.

In which sector is SMO Clinplus Co located?

SMO Clinplus Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von SMO Clinplus Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of SMO Clinplus Co from 6/6/2024 amounting to 0.128 CNY, you needed to have the stock in your portfolio before the ex-date on 6/6/2024.

When did SMO Clinplus Co pay the last dividend?

The last dividend was paid out on 6/6/2024.

What was the dividend of SMO Clinplus Co in the year 2023?

In the year 2023, SMO Clinplus Co distributed 0 CNY as dividends.

In which currency does SMO Clinplus Co pay out the dividend?

The dividends of SMO Clinplus Co are distributed in CNY.

All fundamentals about SMO Clinplus Co

Our stock analysis for SMO Clinplus Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of SMO Clinplus Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.